Business Wire

UPFIELD

9.1.2024 08:58:37 CET | Business Wire | Press release

Share
Upfield Launches World's First Plastic-free, Recyclable Tub for Its Plant Butters and Spreads

Upfield, global leader in plant-based foods, today announces the world's first plastic-free, recyclable tub for its plant butters and spreads.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240108563070/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Upfield launches world's first plastic-free, recyclable tub for its plant butters and spreads (Photo: Business Wire)

Following four years of innovation, in collaboration with Footprint, MCC and Pagès Group, this introduction marks the beginning of Upfield's transition to a paper solution across its portfolio, delivering on the company's ambition to reduce plastic content by 80% by 2030.

Initially launched in Austria with Flora Plant towards the end of 2023, Upfield expects further scaling of its paper solution, aiming to replace up to two billion plastic tubs by 2030, avoiding more than 25,000 tons of plastic waste per year.

The pioneering paper tubs were developed with Upfield’s leading Research & Development team utilising Footprint's material sciences technology. They are made from compressed wet paper fibres and are waterproof, oil-proof, and recyclable in local paper waste streams. The tub has received Conventional Plastic Free Certification and uses paper from a PEFC-certified supplier. Upfield expects the packaging to achieve home compostability certification by 2025.

David Haines, Group CEO for Upfield, commented, "As a global leader in plant-based foods, we take our responsibility to make a positive impact on the world seriously. Globally, 40% of all plastic produced is for packaging that is used once and then discarded, it is clear that the issue of plastic waste is one of the most critical facing our environment. When we established Upfield, innovating our way out of plastic tubs was our moon-shot and I am very proud of all Upfielders that continue to work towards this goal. Consumers today demand products that benefit both people and the planet. Our plant butters and spreads do exactly that. We're excited about the potential to launch this across our most iconic brands in some of our most important markets."

Unlike many paper packaging solutions, Upfield's paper tubs do not have a plastic liner so they can be recycled along with other paper and cardboard household waste, as verified by a leading European recycling company.

Karina Cerdeira, Head of Packaging for Upfield, said, "We are proud to have created, with Footprint, an innovative paper-based tub that is durable, oil-resistant and appealing and which many thought would be impossible with paper. But after years of dedicated focus from joint Upfield and Footprint R&D teams and dozens of prototypes, we made the impossible, possible. This new paper tub marks a true milestone for sustainable packaging that significantly minimises reliance on plastic. We will continue pushing boundaries through further innovation to adapt for compostability, develop new sizes and formats, and refine towards the optimal solution. We hope what we've achieved inspires other businesses to keep pursuing positive change."

Yoke Chung, Co-founder and Chief Technology & Innovation Officer for Footprint, added, "Footprint's commitment to a more sustainable planet is showcased through our partnership with Upfield. The introduction of a ground-breaking solution, in collaboration with Upfield establishes a pioneering industry standard. This marks the introduction of the first oil-resistant paper tub for plant-based spreads. We are proud to collaborate with Upfield on this transformative endeavour, as it resonates with our shared objective of assisting customers in realizing their sustainability goals. This collaborative effort underscores the transformative influence of innovation in fostering positive environmental change to shape a brighter future for everyone."

To stay up to date on the journey, follow @UpfieldGlobal on social or visit Upfield.com.

About Upfield

Upfield is a global leader in plant-based food, operating in four categories – butters and spreads, creams, liquids and cheeses. Over the last four years, Upfield has been on a journey to separate, stabilise, transform, and turn around our platform which today is unique in the plant-based space – combining scale of historical reach and scale of future growth ambition. We are built on the foundation of our power brands, which achieve high Brand Power Index versus wider consumer goods brands in all our key markets. Our brands are built upon our heritage of 150 years of knowledge of plant-based foods, deep R&D expertise, with 15 manufacturing sites across five continents and an end-to-end supply chain ensuring best service and delivery for our customers and consumers. Upfield's processes, products and people combine to create a business where our portfolio and purpose are completely aligned. www.upfield.com

About Footprint

Footprint is a global materials science and technology company with a clear vision to create a healthier planet and healthier people. Our mission is to provide solutions to eliminate single-use plastics in our food chain. Footprint's engineers use plant-based fiber technology to design, develop, and manufacture bio-based products. Footprint is rapidly expanding into new categories with customized and patented solutions for customers. While working with leading global consumer brands, Footprint's products have already led to a worldwide reduction of millions of pounds of plastic waste from entering the environment.

Footprint was founded in 2014 and employs approximately 2,000 people with operations in the U.S., Mexico, Europe, and Asia. Footprint was named to Fast Company's “Brands that Matter” list in 2022, CNBC’s “Disruptor 50” list in 2021, and Fortune’s “Change the World” list in 2020.

For more information on Footprint’s sustainable solutions, visit www.footprintus.com.

MCC Labels provides the label for the paper tub and Pagès the equipment (robot system) to apply the label.

About MCC Verstraete

MCC Verstraete has over 30 years of experience in offset-printing labels for injection molding, blow molding and thermoforming. In-depth understanding of materials, innovation and sustainability have made MCC Verstraete a world leader, producing over 60 million in mold labels every single day for numerous segments within the packaging industry. The drive for innovation recently led to 2 new product categories: next to polypropylene in mold labels, MCC Verstraete offers Molded Fiber Labeling™ and PP heat-seal die-cut lidding. MCC Verstraete has production sites in Belgium, Australia and the US. Together with MCC Korsini (Turkey) and Karydakis IML SA (Greece), MCC Verstraete forms the IML Business Unit within Multi-Color Corporation.

Visit iml.mcclabel.com/en for more information.

About Pagès Group

Pagès Group is a worldwide company with more than 40 years of expertise in decoration solutions and downstream automation for the packaging industry. The group has subsidiaries in France, in the Netherlands, the USA, Canada and China. As of today, more than 3000 automation systems have been installed in more than 45 countries. Among others, we developed Molded Fiber Labeling (MFL™), a world premiere decoration technology to decorate fiber molded containers for a sustainable and stunning packaging. To learn more about Pagès Group automation solutions, please visit www.pagesgroup.net or follow us on LinkedIn.

About EMSUR

EMSUR is the business unit of Grupo Lantero that provides flexible packaging solutions mainly for the food and beverage sector, home and personal care products, with lamination and printing in both rotogravure and flexography.

It currently has production sites in Europe and America, which allows to develop its activity in more than 80 countries across America, Europe, Africa and Asia. Emsur produces almost 600 million square metres of sleeves, lids, banners, labels, die-cuts, pouches and other flexible products per year.

Innovation, developed through the Innotech team and facilities, is one of their key pillars. Visit www.emsur.com for more information.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240108563070/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing5.2.2026 07:30:00 CET | Press release

Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa; “Fujirebio”), a consolidated subsidiary of H.U. Group Holdings, Inc. (HQ: Minato-ku, Tokyo; Chairman, President and Group CEO: Shigekazu Takeuchi) and Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano, “Sysmex”) have agreed on a sales collaboration for dementia testing. This agreement follows continued discussions based on the Basic Agreement on Business Collaboration in the Field of Immunoassay concluded in October 2023.1 Sysmex will exclusively sell Fujirebio's fully automated Lumipulse® immunoassay systems and dementia-related reagents ("the Products") in regions and countries mutually agreed upon by both companies. Going forward, Fujirebio and Sysmex will collaborate to meet the growing testing needs accompanying the wider adoption of therapeutic drugs and will gradually expand the countries where the Products are sold. Since entering into the Basic Agreement on Business Collaboration in Octob

Invivoscribe® Launches LeukoStrat® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide5.2.2026 06:30:00 CET | Press release

Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat®KMT2A + MRD Assay and Software to its industry-leading oncology portfolio. The assay leverages digital PCR (dPCR) to support both screening and precise longitudinal MRD monitoring for KMT2A rearrangements in acute myeloid leukemia (AML) subjects. This quantitative test is currently available for research use in clinical trials and as a stand-alone kit for purchase by our global customers, and will soon be available as a service in our regional LabPMM® laboratories worldwide. The assay is available to detect key AML-associated KMT2A rearrangements, which account for the vast majority of KMT2A fusion partners in AML1 and those most commonly targeted in menin-inhibitor clinical development programs. Later this year, the assay will be enhanced with four additional KMT2A rearrangements which are frequently found in acute lymphocytic leukemia (ALL), expan

VeriSilicon Enhanced ISP8200-FS Series IP Achieves ASIL B Functional Safety Certification5.2.2026 01:00:00 CET | Press release

Enabling Next-Generation High-Performance Automotive Camera Systems VeriSilicon (688521.SH) today announced its latest enhanced versions of Image Signal Processing (ISP) IP ISP8200-FS series, ISP8200-ES and ISP8200L-ES, featuring improved performance and energy efficiency to better support complex automotive camera systems. These enhanced IPs have successfully achieved ISO 26262 ASIL B functional safety certifications issued by TÜV NORD, an international inspection and certification institution, further validating their suitability and reliability for ADAS and autonomous driving applications. The latest enhanced ISP8200-FS series IP can operate at up to 1.2 GHz and support data processing from up to 16 image sensors. It significantly improves the performance of multi-camera scheduling, enabling flexible data-access capabilities and efficient hardware pipeline utilization for automotive camera systems. The enhanced series IP integrates image processing technologies including Color Noise

Kinaxis Inc. to Host Fourth Quarter 2025 Financial Results Conference Call on March 5, 20264.2.2026 22:30:00 CET | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in supply chain orchestration, today announced that it has scheduled its conference call to discuss the financial results for its fourth quarter and year ended December 31, 2025. The call will be hosted on Thursday, March 5 at 8:30 a.m. Eastern Time by Razat Gaurav, chief executive officer, and Blaine Fitzgerald, chief financial officer, followed by a question and answer period. The Company will report its financial results for the fourth quarter and year after the close of markets on Wednesday, March 4, 2026. CONFERENCE CALL DETAILS DATE: Thursday, March 5, 2026 TIME: 8:30 a.m. Eastern Time WEBCAST: https://events.q4inc.com/attendee/567578009 (available for three months) About Kinaxis Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that

Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota4.2.2026 22:30:00 CET | Press release

Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. The policy went into effect in January 2026 and specifies that ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. “We are pleased that another Blue Cross Blue Shield payer has joined Anthem in making ReActiv8 available to well-selected patients after reviewing the large body of clinical evidence we have built,”said Jason Hannon, CEO of Mainstay Medical. “Patients with intractable chronic low back pain are desperately seeking durable solutions, and ReActiv8 has proven to be a safe and effective solution through six clinical studies with 633 patients treated and 1,950 patient-years of follow-up, including two multi-center, randomized controlled clinical studies. We look forward to

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye